- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
International symposium on nanotechnology and patenting
Increasing R&D budgets from the world's leading governments and international organisations have resulted in a consistent and growing volume of nanotechnologies patent applications.
Whether you are an IP professional, a scientist or a researcher, this will be a unique opportunity for you to network amongst the professionals of your industry in The Hague on 9-11 November 2004.
Co-organised by The European Patent Institute, the Future Technologies Division of the German Association of Engineers, the Licensing Executives Society, the European Commission and the European Patent Office, the International Symposium on Nanotechnology and Patenting aims to inform stakeholders on the role of the European Patent System in protecting IP and provides the platform to share and make known your views on technical and ethical points.
Don't miss this opportunity - enrol today and network at the event where European patent professionals meet with European Nanotechnology experts.
For more information on this event and for booking details, please click here
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Research reveals carbon films can give microchips energy storage capability: International team from Drexel University and Paul Sabatier University reveals versatility of carbon films February 11th, 2016
Creating a color printer that uses a colorless, non-toxic ink inspired by nature February 11th, 2016
SLAC X-ray laser turns crystal imperfections into better images of important biomolecules: New method could remove major obstacles to studying structures of complex biological machines February 11th, 2016
Nanoparticle reduces targeted cancer drug's toxicity February 11th, 2016
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016